UniTTEC Co., Ltd. (000925.SZ) and its subsidiary consortium won the bid for the 1.57 billion yuan Chengdu Metro Line 2 signal system onboard subsystem construction project.
Zhonghe Technology (000925.SZ) announcement, the company recently received a tender from Chengdu Rail Transit Group Co., Ltd...
Announcement from UniTTEC Co., Ltd. (000925.SZ): The company recently received a "Notice of Bid Winning" (Number: Railway Group Middle Character [2024] 029) from Chengdu Rail Transit Group Co., Ltd. (the bidding unit), confirming that the company and its controlling subsidiary, Chengdu Zhonghe Intelligent Rail Transit Technology Co., Ltd., jointly won the bid for the "Chengdu Metro Line 2 Signal System Onboard Subsystem Repair Project" with a contract amount of 157 million RMB.
Project Overview: The project involves replacing the remaining signal onboard subsystem equipment on 60 trains (201-260) of Line 2, including onboard controllers, racks, cages, speed and positioning devices, driver displays, beacon readers, positioning antennas, and cables. The scope of work includes, but is not limited to, equipment supply, removal of existing equipment and installation of new equipment, equipment and software debugging, signal system testing, train testing, integrated testing, interface testing, and other relevant work as required by the bidding unit.
Related Articles

Estun Automation (002747.SZ): The company's H shares have been included in the list of securities eligible for trading under the Hong Kong Stock Connect.

CMSC: First coverage of MIXUE GROUP (02097) with a buy rating, overseas markets expected to open up new growth opportunities.

Joincare Pharmaceutical Group Industry (600380.SH): TSLP monoclonal antibody receives approval for new indication to conduct drug clinical trials.
Estun Automation (002747.SZ): The company's H shares have been included in the list of securities eligible for trading under the Hong Kong Stock Connect.

CMSC: First coverage of MIXUE GROUP (02097) with a buy rating, overseas markets expected to open up new growth opportunities.

Joincare Pharmaceutical Group Industry (600380.SH): TSLP monoclonal antibody receives approval for new indication to conduct drug clinical trials.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


